Ehlert F J, Sawyer G W, Esqueda E E
Department of Pharmacology, College of Medicine, University of California, Irvine 92697-4625, USA.
Life Sci. 1999;64(6-7):387-94. doi: 10.1016/s0024-3205(98)00584-0.
Muscarinic agonists elicit contraction through M3 receptors in most isolated preparations of gastrointestinal smooth muscle, and not surprisingly, several investigators have identified M3 receptors in smooth muscle using biochemical, immunological and molecular biological methods. However, these studies have also shown that the M2 receptor outnumbers the M3 by a factor of about four in most instances. In smooth muscle, M3 receptors mediate phosphoinositide hydrolysis and Ca2+ mobilization, whereas M2 receptors mediate an inhibition of cAMP accumulation. The inhibitory effect of the M2 receptor on cAMP levels suggests an indirect role for this receptor; namely, an inhibition of the relaxant action of cAMP-stimulating agents. Such a function has been rigorously demonstrated in an experimental paradigm where gastrointestinal smooth muscle is first incubated with 4-DAMP mustard to inactivate M3 receptors during a Treatment Phase, and subsequently, the contractile activity of muscarinic agonists is characterized during a Test Phase in the presence of histamine and a relaxant agent. When present together, histamine and the relaxant agent (e.g., isoproterenol or forskolin) have no net contractile effect because their actions oppose one another. However, under these conditions, muscarinic agonists elicit a highly potent contractile response through the M2 receptor, presumably by inhibiting the relaxant action of isoproterenol or forskolin on histamine-induced contractions. This contractile response is pertussis toxin-sensitive, unlike the standard contractile response to muscarinic agonists, which is pertussis toxin-insensitive. When measured under standard conditions (i.e., in the absence of histamine and without 4-DAMP mustard-treatment), the contractile response to muscarinic agonists is moderately sensitive to pertussis toxin if isoproterenol or forskolin is present. Also, pertussis toxin-treatment enhances the relaxant action of isoproterenol in the field-stimulated guinea pig ileum. These results demonstrate that endogenous acetylcholine can activate M2 receptors to inhibit the relaxant effects of beta-adrenoceptor activation on M3 receptor-mediated contractions. An operational model for the interaction between M2 and M3 receptors shows that competitive antagonism of the interactive response resembles an M3 profile under most conditions, making it difficult to detect the contribution of the M2 receptor.
在大多数离体胃肠道平滑肌制剂中,毒蕈碱激动剂通过M3受体引发收缩,不出所料,一些研究人员已使用生化、免疫和分子生物学方法在平滑肌中鉴定出M3受体。然而,这些研究还表明,在大多数情况下,M2受体的数量比M3受体多约四倍。在平滑肌中,M3受体介导磷酸肌醇水解和Ca2+动员,而M2受体介导对cAMP积累的抑制。M2受体对cAMP水平的抑制作用表明该受体具有间接作用;即,抑制cAMP刺激剂的舒张作用。在一个实验范式中已严格证明了这种功能,在该范式中,首先在处理阶段将胃肠道平滑肌与4-DAMP芥子气一起孵育以使M3受体失活,随后,在组胺和舒张剂存在的测试阶段对毒蕈碱激动剂的收缩活性进行表征。当组胺和舒张剂(例如异丙肾上腺素或福斯可林)同时存在时,它们没有净收缩作用,因为它们的作用相互拮抗。然而,在这些条件下,毒蕈碱激动剂通过M2受体引发高效的收缩反应,大概是通过抑制异丙肾上腺素或福斯可林对组胺诱导的收缩的舒张作用。这种收缩反应对百日咳毒素敏感,这与对毒蕈碱激动剂的标准收缩反应不同,后者对百日咳毒素不敏感。在标准条件下(即,在没有组胺且未用4-DAMP芥子气处理的情况下)测量时,如果存在异丙肾上腺素或福斯可林,对毒蕈碱激动剂的收缩反应对百日咳毒素中度敏感。此外,百日咳毒素处理增强了异丙肾上腺素在电场刺激的豚鼠回肠中的舒张作用。这些结果表明,内源性乙酰胆碱可激活M2受体,以抑制β-肾上腺素能受体激活对M3受体介导的收缩的舒张作用。M2和M3受体之间相互作用的操作模型表明,在大多数情况下,相互作用反应的竞争性拮抗类似于M3特征曲线,因此难以检测M2受体的作用。